Huaxun Wu | Toxicology and Pharmaceutical Science | Outstanding Contribution Award

Dr. Huaxun Wu | Toxicology and Pharmaceutical Science | Outstanding Contribution Award

Anhui Medical University | China

Dr. Huaxun Wu is an accomplished pharmacologist and Associate Professor at Anhui Medical University, serving as a Master’s Supervisor with a strong record of academic leadership, research excellence, and translational impact in anti-inflammatory immunopharmacology and clinical pharmacology. He holds both MD and PhD degrees in Pharmacology and has established himself as a recognized contributor to pharmacological science through sustained competitive funding, high-quality publications, and active service within national and provincial academic societies. Dr. Wu has served as Principal Investigator for multiple prestigious research programs, including the National Natural Science Foundation of China (Youth Program), the Anhui Provincial Natural Science Foundation (General Program), the Anhui Provincial Key Program for Outstanding Young Talents in Universities, and the Anhui Provincial Key Program for Natural Science Research in Higher Education Institutions. These projects focus on the mechanisms of inflammation, immune regulation, and pharmacological intervention, contributing to improved understanding of drug targets and therapeutic strategies in inflammatory and immune-related diseases. With more than 30 peer-reviewed academic publications, including over 20 SCI-indexed articles, Dr. Wu’s work has achieved significant international visibility, reflected in more than 1,183 citing articles. His research demonstrates a strong balance between fundamental pharmacological discovery and methodological rigor. In addition to journal publications, he has contributed substantially to pharmacological education and research methodology through the publication of authoritative textbooks, including Pharmacological Experimental Methodology (4th Edition) and Pharmacological Research Methodology, which are widely used in academic and clinical training. Dr. Wu’s innovation capacity is further evidenced by his intellectual property portfolio, which includes one granted national patent and three granted PCT patents, underscoring the translational potential and practical relevance of his research outputs. His editorial involvement with the Chinese Pharmacology Bulletin reflects peer recognition of his expertise and commitment to maintaining high scientific standards.

Citation Metrics (Scopus)

2000
1000
500
400
300
200
100
50
30
10
0

Citations
1784

Documents
76

h-index
28

Citations

h-index

i10-index

View Scopus Profile

Featured Publications